Blood Systems Inc

“The Executive Committee has the powers of the Board of Trustees between Board meetings, unless prohibited by law or the Articles of Incorporation. The Executive Committee is composed of 6 or more Trustees, including the Chair, Vice Chair, Secretary-Treasurer, and three or more Trustees selected by the Board of Trustees.”

“Effective September 24, 2018, Blood Systems, Inc. legally changed its name to Vitalant. Accordingly, Vitalants Articles of Organization and Amended and Restated Bylaws were amended to reflect this legal name change.”

“The Form 990 is reviewed by management, including confirmation of compensation disclosures against W-2 and 1099 reporting. A copy of the draft Form 990 and all schedules is supplied to all Board members prior to the meeting held to accept the returns. the W-2s and 1099s are available for Board review upon request. The paid preparer, Ernst & Young, and members of management review the Form 990 with the committees and are available for answering questions. Any comments from the Board are considered prior to filing with the IRS.”

“Each year, the Board of Trustees and senior management are required to sign and return a Conflict of Interest form to company counsel. Any conflicts disclosed are discussed in Executive Session with the Board's Audit Committee and resolved. In addition, in preparation for the Form 990 filing, the Trustees, Officers, and Key Employees identified are required to respond to a comprehensive Conflict of Interest and Family Relationship questionnaire. Any conflicts disclosed are discussed with the Board's Audit Committee and disclosed appropriately on the form 990.”

“The Board of Trustees has a Compensation and Human Resource Committee whose purpose, among other things, is to hire an independent consulting firm once every 2-3 years to provide data on competitiveness of salaries and benefits for the CEO and other officers of the corporation. The members of the Human Resource and Compensation Committee of the Board are all independent trustees and include no members of management. The recommendations of the Committee are reviewed by the entire Board prior to approval. Compensation for these individuals is set and approved by the Board each year. the results of these discussions, reviews and approvals are documented in the Executive Session minutes of the Board meetings. This process was last completed in 2017.”

“Upon written request to the Chief Financial Officer, a copy of the Form 990 will be mailed to the requester. The Form 990 for current and past years is also posted on Guidestar for organizations to access. The governing documents and Conflict of Interest Policy are not made available to the public. The organization's combined financial statements are made available upon request.”

“VITALANT EXISTS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. Vitalant, one of the nations oldest and largest nonprofit community blood service providers, supplies comprehensive transfusion medicine services to nearly 1,000 hospitals and health care partners for patients in need across 40 states. FOrm 990, Part III, Line 2 EFFECTIVE JANUARY 1, 2019 BERGEN COMMUNITY REGIONAL BLOOD CENTER ("BCRBC") MERGED INTO VITALANT. VITALANT IS THE SURVIVING ENITY. BCRBC CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF VITALANT.”

“4A) Blood Services Division - Blood Banking The primary purpose of the Blood Services Division (BSD) is to provide a safe and stable supply of blood and blood components to hospitals adn medical facilities. The strength of BSD is that is operates as local blood centers that are part of the community and yet has access to a large networked organization with all the advantages and efficiencies that are realized through standardization and economies of scale. BSD collects blood from volunteer donors, performs screening and testing on the donated blood, and processes the whole blood into blood components such as red cells platelets and plasma. Blood and blood components ar then stored and distributed to hospitals and other health care providers. 4B) Vitalant Laboratories (VL; formerly Blood Systems Laboratories) Vitalant Laboratories' staff of highly trained and experienced personnel provide support and expertise to hospitals, transfusion and transplant centers and other healthcare facilities for their transfusion medicine needs. VL operates three laboratories for (IRL) Immunohematology Reference Lab, (HLA) Histocompatibility Laboratory and (CTL) Cellular Therapy Laboratory in Phoenix. The members and affiliates of Vitalant operate additional laboratories in San Francisco, Denver, Spokane and San Bernardino. Together they solve some of the most complex immunohematologic compatibility cases and ensure life-saving blood and cellular therapy services to hospitals all across the United States.For healthcare facilities in central Arizona, VL also serves as a blood bank, providing complete transfusion services including patient compatibility testing and delivery. 4C) Vitalant Research Institute (VRI; formerly Blood Systems Research Institute) The Vitalant Research Institute carries out studies funded by extramural grants (NIH and other agencies) and well over $3.5-4.5M each year by Vitalant itself. VRI has historically been noted for contributions to infectious disease testing / monitoring, epidemiology / public policy, and selected non-infectious risks of transfusion. Recent research efforts include characterization of metabolic and genetic factors that influence red blood cell stability, as well as investigation of novel methods for platelet cryopreservation. A public service, VRIs research extends far beyond organizational development efforts, benefiting patients all over the US (and the world) as well as competing US blood centers, improving blood product quality, recipient safety, and the donor experience. VRI supports training programs for specialists in transfusion medicine and the development of epidemiology research scientists. VRI investigators published 94 peer-reviewed original research papers in 2018 along with many more reviews, editorials, book chapters and scientific meeting abstracts. Together, VRIs 10 investigators, 2 clinical investigators, 13 affiliated investigators, 8 core leaders, 6 administrative staff and ~55 scientists, technologists and post-docs have contributed to major discoveries in transfusion safety and efficacy.”

“Pension expense other than net periodic cost $ 3,724,356 ------------ total $ 3,724,356”